Below is a clear evidence‑based fact check using the latest research (2025–2026).

✅ Fact Check: Do fecal transplant pills improve cancer treatment response?

Answer: Yes — early clinical evidence from 2025–2026 shows that fecal microbiota transplant (FMT) capsules (“poop pills”) can improve response to certain cancer treatments, especially immunotherapy.
However, results are from small Phase I/II trials and meta‑analyses, and larger randomized trials are still needed.

🧪 What the Evidence Shows

1. Multiple 2026 clinical trials show improved immunotherapy response

Two Canadian studies published in Nature Medicine (Jan 28, 2026) found that FMT capsules:

• Increased lung cancer immunotherapy response from 39–45% to 80%
• Increased melanoma response from ~50–58% to 75% [medicalxpress.com], [lhscri.ca], [news.westernu.ca]

These were Phase II studies, meaning promising but still preliminary.

2. FMT also reduced toxic side effects in kidney cancer treatment

A Phase I trial found that FMT helped eliminate the toxic side effects of kidney cancer immunotherapy, helping patients stay on treatment longer. [medicalxpress.com], [lhscri.ca], [news.westernu.ca]

3. A 2025 meta‑analysis shows enhanced efficacy when combining FMT + immune checkpoint inhibitors (ICIs)

A meta‑analysis of 10 studies (164 patients) reported:

• Objective response rate (ORR) = 43% overall
• Higher ORR (60%) when combining FMT with anti‑PD‑1 + anti‑CTLA‑4 vs. PD‑1 alone (37%) [link.springer.com]

This provides supportive, though early, pooled evidence.

4. 2025 systematic review confirms mechanism and feasibility

A 2025 review in Cancer Treatment Reviews found that FMT:

• Is safe and feasible during cancer therapy
• May enhance treatment response by altering the gut microbiome
• May increase CD8+ T‑cell infiltration, improving immunotherapy response [cancertrea...eviews.com]

5. Early trials in pancreatic cancer also suggest chemo‑response improvement

A 2025 Phase I study is testing FMT capsules (LND101) to enhance chemotherapy response in pancreatic cancer by modifying the tumor microbiome. [news-medical.net]

🧭 Bottom Line

Evidence supports that faecal transplant pills can improve cancer treatment response — particularly immunotherapy — but the evidence is still preliminary.

What is well‑supported:

• Improved immunotherapy response rates in lung cancer and melanoma
• Reduced toxicity of kidney cancer immunotherapy
• Gut microbiome manipulation appears mechanistically relevant

What is not yet proven:

• Long‑term survival benefit
• Large‑scale randomized trial confirmation
• Standardized commercial treatments

📌 Verdict

The statement is TRUE with the caveat that evidence is early‑stage.

FMT capsules do improve response to some cancer treatments in early clinical trials.